Virtual Reality exposure therapy (VRET) is an efficacious treatment for anxiety disorders but has yet to be implemented in regular care settings. This is arguably due to the limitations of the past generation of VR technology, which was expensive, inaccessible, cumbersome and hard to use. With the advent of consumer VR technology, VRET is now ready for implementation in regular care. This multiple-baseline trial will examine the effectiveness of VRET for public speaking anxiety (PSA) when delivered under real-world conditions at an ordinary, non-specialized mental health clinic, by clinical psychologist with only brief VRET training. Participants will either be self-referred specifically for this treatment, or come through ordinary clinical channels. Self-rated PSA will serve as primary outcome measure and will be measured three times prior to treatment (at screening and twice after a diagnostic screening telephone interview) , four times after onset, at the end of the treatment period, and three months after treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
23
A series of exposure exercises (speech exercises) in front of a virtual audience, focusing on promoting inhibitory learning, with audio-feedback.
Four-module internet program with weekly therapist guidance, focusing on transitioning to in-vivo exposure in everyday settings.
Department of Psychology
Stockholm, Sweden
Change from baseline: Public Speaking Anxiety Scale
Canonical total score will be used. Measure is self-rated, online. Swedish translation of the original PSAS (Bartholomay \& Houlihan, 2016)
Time frame: Change from baseline: (1) five days after interview, (2) ten days after interview, (3) 7 days post-OST, (4) 14 days post-OST (5) 21 days post-OST (6) 28 days post-OST, (7) 35 days post-OST, (8) 125 days post-PST
Change from baseline: Brunnsviken Brief Quality of life scale
Canonical total score will be used. Measure is self-rated, online.
Time frame: Change from baseline: (1) 7 days post-OST, (4) 35 days post-OST, (5) 125 days post-PST
Change from baseline: Liebowitz Social Anxiety Scale Self-Report
Canonical total score will be used. Measure is self-rated, online.
Time frame: Change from baseline: (1) 7 days post-OST, (2) 35 days post-OST, (3) 125 days post-PST
Change from baseline: Brief Fear of Negative Evaluation Scale
Canonical total score will be used. Measure is self-rated, online.
Time frame: Change from baseline: (1) 7 days post-OST, (2) 35 days post-OST, (3) 125 days post-PST
Change from baseline: Patient Health Questionnaire 9-item
Canonical total score will be used. Measure is self-rated, online.
Time frame: Change from baseline: (1) 7 days post-OST, (2) 35 days post-OST, (3) 125 days post-PST
Change from baseline: Generalized Anxiety Disorder 7-item
Canonical total score will be used. Measure is self-rated, online.
Time frame: Change from baseline: (1) 7 days post-OST, (2) 35 days post-OST, (3) 125 days post-PST
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.